Director, Commercial Analytics and Enablement

United States·Bothellexecutive

OtherCommercial

0 views0 saves0 applied

Apply Now

Quick Summary

Key Responsibilities

proactive scorecards, alerts, and readouts; pull: governed self-service dashboards) with clear ownership, refresh expectations, and version control.

Technical Tools

OtherCommercial

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

Position Overview

Immunome is building the commercial capabilities required to prepare for launch and scale a high-performing field organization. The Director, Commercial Analytics & Enablement will own the strategy, roadmap, and operating model for commercial analytics and enablement, connecting targeting, insights, governance, and execution discipline across Commercial.

This leader will be responsible for designing and operationalizing foundational commercial execution components—including field force design inputs, targeting/segmentation and call planning refresh cycles, incentive compensation philosophy and plan design/administration/governance, commercial performance visualization and reporting strategy, and commercial analytics —while supporting core commercialization governance routines.

Responsibilities